Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: billy d who wrote (1387)	11/8/1998 9:36:00 PM
From: Ed Ajootian	of 10280

Billy, I think there would be a delayed reaction to any news on Oxy getting by Phase II and even the intermediate-term effect would not be huge. Biggest reason is that this is not an area of Sepracor's expertise and they do not have a way to market the drug and would need a partner. Speaking of which, I forgot who makes Ditopran. They obviously would be the logical choice. Still, something pretty big must be in the offing to make this thing approach a $3 billion market cap. All we need is one more day like Friday and we're there! Wondering at what point the latter convertible bond holders will start shorting against the box to lock in their profits. Their bonds are not callable for over 2 years but if they can lock in a sure double (ie SEPR stock price of $80) some of the more conservative ones may do it.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next